Wells Fargo & Company Cara Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 1,086 shares of CARA stock, worth $314. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,086
Previous 1,226 11.42%
Holding current value
$314
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$0.26 - $0.38 $36 - $53
-140 Reduced 11.42%
1,086 $0
Q2 2024

Aug 13, 2024
SELL
$0.24 - $0.92 $4,368 - $16,744
-18,201 Reduced 93.69%
1,226 $0
Q1 2024

May 10, 2024
BUY
$0.52 - $1.05 $527 - $1,065
1,015 Added 5.51%
19,427 $17,000
Q4 2023

Feb 09, 2024
SELL
$0.6 - $1.65 $7,392 - $20,329
-12,321 Reduced 40.09%
18,412 $13,000
Q3 2023

Nov 13, 2023
SELL
$1.67 - $3.33 $23,353 - $46,566
-13,984 Reduced 31.27%
30,733 $51,000
Q2 2023

Aug 15, 2023
BUY
$2.83 - $4.94 $13,691 - $23,899
4,838 Added 12.13%
44,717 $126,000
Q1 2023

May 12, 2023
BUY
$4.89 - $12.27 $24,014 - $60,257
4,911 Added 14.04%
39,879 $195,000
Q4 2022

Feb 13, 2023
SELL
$8.88 - $12.77 $283,094 - $407,107
-31,880 Reduced 47.69%
34,968 $375,000
Q3 2022

Nov 14, 2022
SELL
$8.24 - $12.56 $33,808 - $51,533
-4,103 Reduced 5.78%
66,848 $626,000
Q2 2022

Aug 12, 2022
SELL
$7.45 - $13.84 $303,647 - $564,090
-40,758 Reduced 36.49%
70,951 $647,000
Q1 2022

May 16, 2022
SELL
$9.94 - $12.65 $209,574 - $266,712
-21,084 Reduced 15.88%
111,709 $1.36 Million
Q4 2021

Feb 14, 2022
SELL
$11.99 - $18.14 $653,958 - $989,391
-54,542 Reduced 29.11%
132,793 $1.62 Million
Q3 2021

Nov 15, 2021
SELL
$11.55 - $16.06 $421,875 - $586,607
-36,526 Reduced 16.32%
187,335 $2.89 Million
Q2 2021

Aug 16, 2021
BUY
$12.38 - $29.19 $969,155 - $2.29 Million
78,284 Added 53.77%
223,861 $3.19 Million
Q1 2021

May 13, 2021
BUY
$15.07 - $21.71 $284,657 - $410,080
18,889 Added 14.91%
145,577 $3.16 Million
Q4 2020

Feb 09, 2021
BUY
$12.72 - $16.16 $239,110 - $303,775
18,798 Added 17.42%
126,688 $1.92 Million
Q3 2020

Nov 05, 2020
SELL
$12.34 - $17.92 $139,479 - $202,549
-11,303 Reduced 9.48%
107,890 $1.37 Million
Q2 2020

Aug 13, 2020
BUY
$12.39 - $17.33 $181,117 - $253,329
14,618 Added 13.98%
119,193 $2.04 Million
Q1 2020

May 14, 2020
BUY
$9.12 - $17.78 $953,723 - $1.86 Million
104,575 New
104,575 $1.38 Million

Others Institutions Holding CARA

# of Institutions
74
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $15.6M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email